Ravi Visswanathan

423 total citations
3 papers, 38 citations indexed

About

Ravi Visswanathan is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ravi Visswanathan has authored 3 papers receiving a total of 38 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Oncology, 1 paper in Genetics and 1 paper in Pulmonary and Respiratory Medicine. Recurrent topics in Ravi Visswanathan's work include Pancreatic and Hepatic Oncology Research (2 papers), Nanoparticle-Based Drug Delivery (1 paper) and Cancer Genomics and Diagnostics (1 paper). Ravi Visswanathan is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Nanoparticle-Based Drug Delivery (1 paper) and Cancer Genomics and Diagnostics (1 paper). Ravi Visswanathan collaborates with scholars based in United States and Japan. Ravi Visswanathan's co-authors include Judy Lucas, Gang Li, Paolo Vicini, Erica L. Bradshaw‐Pierce, Mary E. Spilker, Xiaoying Chen, Shinji Yamazaki, Zhenhua Gu, Christopher L. Holliman and Chandrasekar Durairaj and has published in prestigious journals such as Analytical Chemistry, Clinical Cancer Research and Clinical Pharmacology in Drug Development.

In The Last Decade

Ravi Visswanathan

3 papers receiving 36 citations

Peers

Ravi Visswanathan

MB

PRM

ONCOL

BE

PS

Alberto Martín‐Lorenzo Spain

Danny Shih United States

Yujia He China

Cristian Ruiz-Moreno Netherlands

Joseph M. Gurski United States

Zhijun Liang China

Andy He United States

C. Raventós Spain

Linmao Wang China

N. Chatterjee India

Alberto Martín‐Lorenzo Spain

Ravi Visswanathan

20 ×1.4

MB

3 ×0.3

PRM

8 ×1.0

ONCOL

15 ×2.5

BE

3 ×0.8

PS

Citations per year, relative to Ravi Visswanathan Ravi Visswanathan (= 1×) peers Alberto Martín‐Lorenzo

Countries citing papers authored by Ravi Visswanathan

Since Specialization

Citations

This map shows the geographic impact of Ravi Visswanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Visswanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Visswanathan more than expected).

Fields of papers citing papers by Ravi Visswanathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Visswanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Visswanathan. The network helps show where Ravi Visswanathan may publish in the future.

Co-authorship network of co-authors of Ravi Visswanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Visswanathan. A scholar is included among the top collaborators of Ravi Visswanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Visswanathan. Ravi Visswanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

3 of 3 papers shown

1.

Visswanathan, Ravi, et al.. (2019). Bioanalysis of Targeted Nanoparticles in Monkey Plasma via LC-MS/MS. Analytical Chemistry. 91(21). 13874–13882. 11 indexed citations

2.

Houk, Brett E., Christine Alvey, Ravi Visswanathan, et al.. (2018). Distribution, Metabolism, and Excretion of Gedatolisib in Healthy Male Volunteers After a Single Intravenous Infusion. Clinical Pharmacology in Drug Development. 8(1). 22–31. 4 indexed citations

3.

Spilker, Mary E., Xiaoying Chen, Ravi Visswanathan, et al.. (2016). Found in Translation: Maximizing the Clinical Relevance of Nonclinical Oncology Studies. Clinical Cancer Research. 23(4). 1080–1090. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact